Shandong Buchang Pharmaceuticals Co., Ltd. (SHA: 603858)
China flag China · Delayed Price · Currency is CNY
17.30
-0.15 (-0.86%)
Nov 13, 2024, 3:00 PM CST

Shandong Buchang Pharmaceuticals Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Net Income
-293.31318.97-1,5301,2891,8611,946
Upgrade
Depreciation & Amortization
426.56426.56497.56510.43424.55386.08
Upgrade
Other Amortization
230.72230.7238.193.482.033.07
Upgrade
Loss (Gain) From Sale of Assets
-1.53-1.53-0.77-1.68-1.13-0.13
Upgrade
Asset Writedown & Restructuring Costs
602.34602.342,94412.421.913.56
Upgrade
Loss (Gain) From Sale of Investments
-18.94-18.9454.0642.39-15.62-58.76
Upgrade
Provision & Write-off of Bad Debts
7.987.984.4115.121.45-22.46
Upgrade
Other Operating Activities
1,703-22.1972.17100.81107.6127.93
Upgrade
Change in Accounts Receivable
83.6883.68483.36363.14-648.66640.33
Upgrade
Change in Inventory
-1,186-1,18639.52-1,066-847.77-537.91
Upgrade
Change in Accounts Payable
-493.59-493.59172.0192.541,058209.78
Upgrade
Operating Cash Flow
917.66-195.612,7561,3211,9592,621
Upgrade
Operating Cash Flow Growth
1298.23%-108.68%-32.58%-25.28%27.82%
Upgrade
Capital Expenditures
-332.84-529.92-543.17-433.53-536.44-662.11
Upgrade
Sale of Property, Plant & Equipment
12.40.481.4510.230.52
Upgrade
Cash Acquisitions
0.750.75--272.766.43-20.27
Upgrade
Divestitures
-0.2-0.2--0.0421.66-
Upgrade
Investment in Securities
2.12328.37-478.96-46.91-28.51-11.93
Upgrade
Other Investing Activities
6.8830.611.4796.0544.91-576.4
Upgrade
Investing Cash Flow
-322.29-168-1,010-655.67-421.72-1,270
Upgrade
Long-Term Debt Issued
-1,5052,2953,1733,0792,269
Upgrade
Total Debt Issued
2,1141,5052,2953,1733,0792,269
Upgrade
Short-Term Debt Repaid
------0.57
Upgrade
Long-Term Debt Repaid
--1,355-2,722-3,154-2,438-1,794
Upgrade
Total Debt Repaid
-1,386-1,355-2,722-3,154-2,438-1,795
Upgrade
Net Debt Issued (Repaid)
727.18150.1-426.9618.9641.75474.83
Upgrade
Repurchase of Common Stock
-9.99-9.99----740
Upgrade
Common Dividends Paid
-269.76-1,194-547.34-746.21-2,488-920.58
Upgrade
Other Financing Activities
-559.3-11.24-13.27-43.57-39.5-39.86
Upgrade
Financing Cash Flow
-111.87-1,065-987.57-770.88-1,886-1,226
Upgrade
Foreign Exchange Rate Adjustments
-0.010.010.16-0.34-0.010
Upgrade
Net Cash Flow
483.49-1,429758.04-106.38-348.95125.54
Upgrade
Free Cash Flow
584.82-725.522,212886.981,4221,959
Upgrade
Free Cash Flow Growth
--149.44%-37.64%-27.40%164.40%
Upgrade
Free Cash Flow Margin
4.97%-5.48%14.80%5.63%8.89%13.74%
Upgrade
Free Cash Flow Per Share
0.53-0.662.000.801.291.76
Upgrade
Cash Interest Paid
--5.02---
Upgrade
Cash Income Tax Paid
1,3671,8191,9152,3082,1162,460
Upgrade
Levered Free Cash Flow
1,194-558.661,955915.43869.91,519
Upgrade
Unlevered Free Cash Flow
1,269-489.952,0401,020960.561,604
Upgrade
Change in Net Working Capital
-587.271,265-937.07148.37358.85-454.62
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.